Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Reckitt Benckiser Healthcare (UK) Limited, Dansom Lane, Hull, HU8 7DS, United Kingdom
Senokot 7.5 mg/5 ml Syrup.
| Pharmaceutical Form |
|---|
|
Syrup. Amber, slightly viscous liquid. |
Each 5 ml of Senokot Syrup contains calcium sennosides equivalent to 7.5 mg per 5 ml total sennosides (calculated as sennoside B).
Also contains maltitol syrup (E965), methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216) and ethanol.
For full list of excipients, see Section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Sennosides |
The sugar moiety of the sennosides is removed by bacteria in the large intestine releasing the active anthrone fraction. This stimulates peristalsis via the submucosal and myenteric nerve plexuses. |
| List of Excipients |
|---|
|
Potassium sorbate E202 |
Glass bottle with a polypropylene cap with a polyethylene tamper-evident band with an expanded polyethylene wad containing 100, 150 or 200 ml syrup.
Reckitt Benckiser Healthcare (UK) Limited, Dansom Lane, Hull, HU8 7DS, United Kingdom
PL 00063/0123
8th April 2005
| Drug | Countries | |
|---|---|---|
| SENOKOT | Australia, Ecuador, Hong Kong, Ireland, Mexico, New Zealand, Singapore, Turkey, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
